Chinese Medicine Panax Notoginseng Saponin Dispersible Tablets for Ischemic Cardiovascular Diseases

• Customization: Available
• Application: Department of Cardiology
• Usage Mode: For oral administration
• Model NO.: Z20050647
• Suitable for: Elderly, Children, Adult
• State: Solid
• Shape: Tablet
• Type: Pharmaceutical Products
• Pharmaceutical Technology: Natural Product Extraction
• Drug Reg./Approval No.: Drug Approval Number Z20063741
• Properties: Dispersible Tablets
• Content: 100 Mg of Total Saponins of Panax Notoginseng
• Validity Period: 24 Months
• Transport Package: PVC
• Specification: 9 tablets/plate × 1 plate/box
• Trademark: HJT-Medicine
• Origin: China
• HS Code: 3004905990

Product Description

Product Description

Indications:
 

Promote blood circulation to remove blood stasis and dredge the meridians. It is used for obstruction of cerebral collaterals, hemiplegia due to stroke, obstruction of heart vessels, chest pain caused by heart problems; and for those with sequelae of stroke, angina pectoris of coronary heart disease belonging to the above syndromes.
 

Dosage:

Take orally, 50 - 100 mg (0.5 - 1 tablet) each time, three times a day.

 

Ingredients:
 

Total saponins of Panax notoginseng

Properties:

This product is off-white or slightly yellowish dispersible tablets; it tastes sweet with a slight bitterness.

Specification:

Each tablet weighs 0.3g (containing 100mg of total saponins of Panax notoginseng).

 

 

Drug interactions:

1. It should be used with caution in patients with bleeding tendencies and those with coagulation disorders.
2. It should be used with caution in puerperal women and menstruating women.
3. It should be used with caution in individuals with allergic constitutions and those with abnormal liver and kidney functions.
4. It should be used with caution in pregnant women.

Contraindications:

1. It is contraindicated for those allergic to Panax ginseng and Panax notoginseng.
2. It is contraindicated for those allergic to this product and its ingredients.
3. It is contraindicated during the acute phase of hemorrhagic diseases.

Company Profile

Since 2012, Anhui Hengjingtang Pharmaceutical Co., Ltd. in Anhui Province, China, has been a professional pharmaceutical trading company. It can offer one-stop services for finished pharmaceutical products that meet the requirements of the Standard Good Manufacturing Practice (GMP), as well as the current versions of the British Pharmacopoeia (BP), the United States Pharmacopoeia (USP), and European and American pharmaceutical standards.

Certifications:

Business License, Manufacturing License, Certificate of Pharmaceutical Products (CoPP), Free Sales Certificate (FSC), and technical documents for registration.